TNF and irritable bowel syndrome: In the cholinergic anti-inflammatory system, through an anti-TNF-α, the action of the efferent vagus nerve may be a therapeutic target in IBD by a pharmacological, dietary, or neurostimulation strategy, according to animal studies [28,29].